Identification of microRNAs modulated by DNA hypomethylating drugs in extranodal NK/T-cell lymphoma

References

• Wu WK, Yu J, Chan MT, et al. Combinatorial epigenetic deregulation by Helicobacter pylori and Epstein-Barr virus infections in gastric tumourigenesis. J Pathol. 2016;239:245–249.
   PubMed Web of Science ®Google Scholar
• Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415–428.
   PubMed Web of Science ®Google Scholar
• Matsusaka K, Kaneda A, Nagae G, et al. Classification of Epstein-Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. Cancer Res. 2011;71:7187–7197.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Research Network. Comprehensive molecular characterization of gastric adenocarcinoma. Nature. 2014;513:202–209.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell. 2009;136:215–233.
   PubMed Web of Science ®Google Scholar
• Imig J, Motsch N, Zhu JY, et al. MicroRNA profiling in Epstein-Barr virus-associated B-cell lymphoma. Nucleic Acids Res. 2011;39:1880–1893.
   PubMed Web of Science ®Google Scholar
• Ng SB, Yan J, Huang G, et al. Dysregulated microRNAs affect pathways and targets of biologic relevance in nasal-type natural killer/T-cell lymphoma. Blood. 2011;118:4919–4929.
   PubMed Web of Science ®Google Scholar
• Garzon R, Fabbri M, Cimmino A, et al. MicroRNA expression and function in cancer. Trends Mol Med. 2006;12:580–587.
   PubMed Web of Science ®Google Scholar
• Lujambio A, Calin GA, Villanueva A, et al. A microRNA DNA methylation signature for human cancer metastasis. Proc Natl Acad Sci USA. 2008;105:13556–13561.
   PubMed Web of Science ®Google Scholar
• Bandres E, Agirre X, Bitarte N, et al. Epigenetic regulation of microRNA expression in colorectal cancer. Int J Cancer. 2009;125:2737–2743.
   PubMed Web of Science ®Google Scholar
• Asano N, Kato S, Nakamura S. Epstein-Barr virus-associated natural killer/T-cell lymphomas. Best Pract Res Clin Haematol. 2013;26:15–21.
   PubMed Web of Science ®Google Scholar
• Swerdlow SH, Campo E, Harris NL, et al, editors. WHO classification of tumors of haematopoietic and lymphoid tissues. Revised 4th ed. Lyon: IARC Press; 2016.
   Google Scholar
• Iqbal J, Weisenburger DD, Chowdhury A, et al. Natural killer cell lymphoma shares strikingly similar molecular features with a group of non-hepatosplenic gammadelta T-cell lymphoma and is highly sensitive to a novel aurora kinase A inhibitor in vitro. Leukemia. 2011;25:348–358.
   PubMed Web of Science ®Google Scholar
• Huang Y, de Reynies A, de Leval L, et al. Gene expression profiling identifies emerging oncogenic pathways operating in extranodal NK/T-cell lymphoma, nasal type. Blood. 2010;115:1226–1237.
   PubMed Web of Science ®Google Scholar
• Ng SB, Selvarajan V, Huang G, et al. Activated oncogenic pathways and therapeutic targets in extranodal nasal-type NK/T cell lymphoma revealed by gene expression profiling. J Pathol. 2011;223:496–510.
   PubMed Web of Science ®Google Scholar
• Huang Y, de Leval L, Gaulard P. Molecular underpinning of extranodal NK/T-cell lymphoma. Best Pract Res Clin Haematol. 2013;26:57–74.
   PubMed Web of Science ®Google Scholar
• Kucuk C, Hu X, Jiang B, et al. Global promoter methylation analysis reveals novel candidate tumor suppressor genes in natural killer cell lymphoma. Clin Cancer Res. 2015;21:1699–1711.
   PubMed Web of Science ®Google Scholar
• Siu LL, Chan JK, Wong KF, et al. Aberrant promoter CpG methylation as a molecular marker for disease monitoring in natural killer cell lymphomas. Br J Haematol. 2003;122:70–77.
   PubMed Web of Science ®Google Scholar
• Siu LL, Chan JK, Wong KF, et al. Specific patterns of gene methylation in natural killer cell lymphomas: p73 is consistently involved. Am J Pathol. 2002;160:59–66.
   PubMed Web of Science ®Google Scholar
• Paik JH, Jang JY, Jeon YK, et al. MicroRNA-146a downregulates NFkappaB activity via targeting TRAF6 and functions as a tumor suppressor having strong prognostic implications in NK/T cell lymphoma. Clin Cancer Res. 2011;17:4761–4771.
   PubMed Web of Science ®Google Scholar
• Andrae J, Gallini R, Betsholtz C. Role of platelet-derived growth factors in physiology and medicine. Genes Dev. 2008;22:1276–1312.
   PubMed Web of Science ®Google Scholar
• Avalle L, Incarnato D, Savino A, et al. MicroRNAs-143 and -145 induce epithelial to mesenchymal transition and modulate the expression of junction proteins. Cell Death Differ. 2017;24:1750–1760.
   PubMed Web of Science ®Google Scholar
• Bai Y, Zhang Y, Hua J, et al. Silencing microRNA-143 protects the integrity of the blood-brain barrier: implications for methamphetamine abuse. Sci Rep. 2016;6:35642.
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Akiyama Y, Otsubo T, et al. Involvement of epigenetically silenced microRNA-181c in gastric carcinogenesis. Carcinogenesis. 2010;31:777–784.
   PubMed Web of Science ®Google Scholar
• Dufva O, Kankainen M, Kelkka T, et al. Aggressive natural killer-cell leukemia mutational landscape and drug profiling highlight JAK-STAT signaling as therapeutic target. Nat Commun. 2018;9:1567.
   PubMed Web of Science ®Google Scholar
• Hongyo T, Hoshida Y, Nakatsuka S, et al. p53, K-ras, c-kit and beta-catenin gene mutations in sinonasal NK/T-cell lymphoma in Korea and Japan. Oncol Rep. 2005;13:265–271.
   PubMed Web of Science ®Google Scholar
• Takahara M, Kishibe K, Bandoh N, et al. P53, N- and K-Ras, and beta-catenin gene mutations and prognostic factors in nasal NK/T-cell lymphoma from Hokkaido, Japan. Hum Pathol. 2004;35:86–95.
   PubMed Web of Science ®Google Scholar
• Mo X, Wei F, Tong Y, et al. Lactic acid downregulates viral microRNA to promote Epstein-Barr virus-immortalized B lymphoblastic cell adhesion and growth. J Virol. 2018;92:pii: 00033-18.
   Web of Science ®Google Scholar
• Lung RW, Hau PM, Yu KH, et al. EBV-encoded miRNAs target ATM-mediated response in nasopharyngeal carcinoma. J Pathol. 2018;244:394–407.
   PubMed Web of Science ®Google Scholar